Standards; Pharmaceutical/API Drug Impurities/Metabolites;
应用:
(5-Bromo-1-benzofuran-2-yl)boronic Acid acts as a reagent for the identification and for the synthesis of furanylpyrimidinamines as Janus kinase inhibitors with potentials for the treatment of oncological and immune inflammatory diseases.
您的位置：
